- Home
- HUM
HUM
Humana Inc.
as 04-21-2025 4:00pm EST
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
| Founded: | 1961 | Country: | United States |
| Employees: | N/A | City: | LOUISVILLE |
| Market Cap: | 34.5B | IPO Year: | 1993 |
| Target Price: | $288.14 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Hold | Number of Analysts: | 22 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.98 | EPS Growth: | -50.10 |
| 52 Week Low/High: | $213.31 - $406.46 | Next Earning Date: | 04-30-2025 |
| Revenue: | $117,761,000,000 | Revenue Growth: | 10.71% |
| Revenue Growth (this year): | 7.67% | Revenue Growth (next year): | 1.80% |
Latest Humana Inc. News
HUM Breaking Stock News: Dive into HUM Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
5 days ago
Google antitrust ruling, UnitedHealth, new Lockheed Martin CFO
StockStory
5 days ago
Why Humana (HUM) Shares Are Getting Obliterated Today
Yahoo Finance
5 days ago
UnitedHealth Q1 earnings signal trouble for Medicare Advantage players
StockStory
5 days ago
2 S&P 500 Stocks with Exciting Potential and 1 to Think Twice About
Business Wire
5 days ago
Humana Board Declares Payment of Quarterly Dividend to Stockholders
Insider Monkey
5 days ago
Jim Cramer: Humana (HUM) Keeps Rising – A “Totally Independent” Healthcare Stock
Healthcare Dive
6 days ago
CMS rejects Humana’s Medicare Advantage star ratings appeal
Business Wire
6 days ago
New Report from the Humana Foundation Examines Best-Practices in Community-Engaged Research
Compare HUM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HUM Humana Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.